½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1537024

À¯¹æ »ý°Ë ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2033³â)

Breast Biopsy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 353 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â ÃÖ±Ù ¼¼°è À¯¹æ »ý°Ë ½ÃÀå¿¡ ´ëÇÑ »ó¼¼ÇÑ Á¶»ç º¸°í¼­¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ½ÃÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µî ÁÖ¿ä ½ÃÀå ¿ªÇп¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®À» ÅëÇØ ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • À¯¹æ »ý°Ë ½ÃÀå ±Ô¸ð(2024E) : 23¾ï ´Þ·¯
  • ¿¹»ó ½ÃÀå °¡Ä¡(2033F) : 38¾ï ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(2024-2033³â CAGR) : 5.7%

À¯¹æ »ý°Ë ½ÃÀå - º¸°í¼­ ¹üÀ§:

À¯¹æ »ý°Ë ½ÃÀå¿¡´Â °Ë»ç¸¦ À§ÇØ ÀÛÀº Á¶Á÷ »ùÇÃÀ» äÃëÇÏ¿© À¯¹æ¾ÏÀ» Áø´ÜÇϱâ À§ÇÑ ´Ù¾çÇÑ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀå¿¡´Â ¾ÏÀÇ Á¶±â ¹ß°ß ¹× Áø´Ü¿¡ ÇʼöÀûÀÎ ¹Ù´Ã »ý°Ë, °³º¹ ¼ö¼ú »ý°Ë, Áø°ø º¸Á¶ »ý°Ë µî ´Ù¾çÇÑ À¯ÇüÀÇ À¯¹æ »ý°ËÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀº º´¿ø, Áø´Ü¼¾ÅÍ, ¿Ü·¡ ¼ö¼ú¼¾ÅÍ µî ´Ù¾çÇÑ ºÎ¹®¿¡ ¼­ºñ½º¸¦ Á¦°øÇÏ°í ÀÖÀ¸¸ç, Á÷ÆÇ ¹× ÀÇ·á¿ëÇ° ÆǸÅÁ¡ µî ´Ù¾çÇÑ Ã¤³ÎÀ» ÅëÇØ À¯ÅëµÇ°í ÀÖ½À´Ï´Ù. À¯¹æ¾Ï °ËÁø¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, À¯¹æ¾Ï À¯º´·ü Áõ°¡, »ý°Ë ±â¼úÀÇ ±â¼úÀû Áøº¸ µîÀÌ ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

À¯¹æ »ý°Ë ¼¼°è ½ÃÀåÀ» À̲ô´Â ¸î °¡Áö ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î À¯¹æ¾Ï ¹ßº´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó À¯¹æ »ý°Ë¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. »ý°Ë Àåºñ¿Í ½Ã¼úÀÇ ±â¼úÀû ¹ßÀüÀº ÀÌ·¯ÇÑ ½Ã¼úÀÇ Á¤È®¼º°ú ÆíÀǼºÀ» Çâ»ó½ÃÄÑ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡ÇÏ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯¹æ¾Ï Á¶±â °ËÁø ¹× Áø´Ü¿¡ ´ëÇÑ Àνİú ³ë·ÂÀÌ ³ô¾ÆÁö¸é¼­ À¯¹æ¾Ï »ý°Ë¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í ¿¹¹æÀû °Ç°­ °ü¸®¿¡ ´ëÇÑ °ü½Éµµ ½ÃÀå È®´ë¿¡ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¾ïÁ¦¿äÀÎ:

À¯¹æ »ý°Ë ½ÃÀåÀº À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸ÇÏ°í °í±Þ »ý°Ë Àåºñ ¹× ½Ã¼úÀÇ ³ôÀº ºñ¿ë, ºÒÆíÇÔ ¹× °¨¿° À§Çè°ú °°Àº ÀáÀçÀû ¹®Á¦¿Í °ü·ÃµÈ °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á±â±â ¾ÈÀü¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦¿Í ÁøÈ­ÇÏ´Â ÀÓ»óÀû ¿ä±¸¿¡ ´ëÀÀÇϱâ À§ÇÑ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀÇ Çʿ伺¿¡ ÀÇÇØ ½ÃÀåµµ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ°í °æÀï·ÂÀ» À¯ÁöÇϱâ À§Çؼ­´Â È¿°úÀûÀΠȯÀÚ ±³À°, °æÀï·Â ÀÖ´Â °¡°Ý Ã¥Á¤, ¿¬±¸°³¹ß¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÅõÀÚ°¡ ÇÊ¿äÇÕ´Ï´Ù.

½ÃÀå ±âȸ:

½ÃÀå °³Ã´Àº Á¤È®ÇÏ°í Æí¾ÈÇÑ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ °íÇ°ÁúÀÇ ÃÖ¼Òħ½ÀÀû »ý°Ë Àåºñ¸¦ °³¹ßÇϱâ À§ÇØ ³ë·ÂÇÏ°í ÀÖ½À´Ï´Ù. ½ÅÈï °æÁ¦±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë´Â ½ÃÀå ¼ºÀåÀ» À§ÇÑ »õ·Î¿î ä³ÎÀ» Á¦°øÇÏ¿© ±â¾÷ÀÌ ´õ ¸¹Àº »ç¶÷µé¿¡°Ô ´Ù°¡°¥ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù. µµ½ÃÈ­ÀÇ ÁøÀü°ú °Ç°­¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ À¯¹æ »ý°Ë¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. Àü·«Àû ÆÄÆ®³Ê½Ê, ½Å±â¼ú¿¡ ´ëÇÑ ÅõÀÚ, Çõ½ÅÀûÀÎ »ý°Ë ÀåºñÀÇ µµÀÔÀº »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ È°¿ëÇÏ°í ½ÃÀå ¸®´õ½ÊÀ» À¯ÁöÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®µé

  • ¼¼°è À¯¹æ »ý°Ë ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • ´Ù¾çÇÑ È¯°æ¿¡¼­ ¾î¶² Á¾·ùÀÇ À¯¹æ »ý°Ë¼ú°ú ¿ëµµ°¡ äÅÃÀ» ÁÖµµÇÏ°í Àִ°¡?
  • ±â¼úÀÇ ¹ßÀüÀº À¯¹æ »ý°Ë ½ÃÀåÀÇ °æÀï »óȲ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÃƽÀ´Ï±î?
  • À¯¹æ »ý°Ë ½ÃÀåÀÇ ÁÖ¿ä Ç÷¹À̾î´Â ´©±¸ÀÌ¸ç °æÀïÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» ÃëÇÏ°í Àִ°¡?
  • ¼¼°è À¯¹æ »ý°Ë ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå¿Í ÇâÈÄ Àü¸ÁÀº?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀå ¹üÀ§/ºÐ·ù
  • ½ÃÀå Á¤ÀÇ/¹üÀ§/Á¦ÇÑ
  • Æ÷ÇÔ°ú ¹èÁ¦

Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä µ¿Çâ
  • Á¦Ç° Çõ½Å/°³¹ß µ¿Çâ

Á¦4Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®

  • Á¦Ç° ä¿ë/»ç¿ë »óȲ ºÐ¼®
  • Á¦Á¶¾÷üº° ÁÖ¿ä ÇÁ·Î¸ð¼Ç Àü·«
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • PESTLE ºÐ¼®
  • Porters ºÐ¼®
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±â¼ú Æò°¡

Á¦5Àå ½ÃÀå ¹è°æ

  • °Å½Ã°æÁ¦ ¿äÀÎ
  • ¿¹Ãø¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
  • ½ÃÀå ¿ªÇÐ

Á¦6Àå COVID-19 À§±â ºÐ¼®

  • COVID-19¿Í ¿µÇ⠺м®
    • Á¦Ç°º° ¸ÅÃâ
    • ÀûÀÀÁõº° ¸ÅÃâ
    • ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ
    • ±¹°¡º° ¸ÅÃâ
  • 2024³â ½ÃÀå ½Ã³ª¸®¿À

Á¦7Àå ¼¼°è ½ÃÀå ¼ö¿ä(¼ö·®) ºÐ¼®

  • ½ÃÀå(¼ö·®) ºÐ¼®, 2019-2023³â
  • ½ÃÀå(¼ö·®) ¿¹Ãø, 2024-2033³â
    • Àü³âºñ ¼ºÀå µ¿Ç⠺м®

Á¦8Àå ¼¼°è ½ÃÀå - °¡°Ý ºÐ¼®

  • Á¦Ç°º° Áö¿ªº° °¡°Ý ºÐ¼®
  • °¡°Ý ³»¿ª
    • Á¦Á¶¾÷ü ·¹º§ °¡°Ý ¼³Á¤
    • À¯Åë¾÷ü ·¹º§ °¡°Ý ¼³Á¤
  • ¼¼°è Æò±Õ °¡°Ý ºÐ¼® º¥Ä¡¸¶Å©
  • °¡°Ý ¼³Á¤ °¡Á¤

Á¦9Àå ¼¼°è ½ÃÀå ¼ö¿ä(±Ý¾×) ºÐ¼®

  • ½ÃÀå(±Ý¾×) ºÐ¼®, 2019-2023³â
  • ½ÃÀå(±Ý¾×) ¿¹Ãø, 2024-2033³â
    • Àü³âºñ ¼ºÀå µ¿Ç⠺м®
    • Àý´ëÀû ¼öÀÍ ±âȸ

Á¦10Àå Á¦Ç°º° : ¼¼°è ½ÃÀå ºÐ¼®

  • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ±Ô¸ð(±Ý¾× ¹× ¼ö·®) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(±Ý¾× ¹× ¼ö·®) ¼®°ú ¿¹Ãø, 2024-2033³â
    • »ý°Ëħ
      • ÄÚ¾î ´Ïµé
      • ¹Ì¼¼ ÈíÀÎħ
    • MRI °¡ÀÌµå »ý°Ë ½Ã½ºÅÛ
    • ÃÊÀ½ÆÄ À¯µµÇÏ À¯¹æ »ý°Ë ½Ã½ºÅÛ
      • 2Â÷¿ø(2D) ¸¾¸ð±×·¡ÇÇ ÃÊÀ½ÆÄ ½ºÄµ ½Ã½ºÅÛ
      • 3Â÷¿ø(3D) B¸ðµå ¸¾¸ð±×·¡ÇÇ ÃÊÀ½ÆÄ ½ºÄµ ½Ã½ºÅÛ
    • ÈíÀÎ º¸Á¶ ±â±â(VAD)
    • °¡À̵å¿ÍÀ̾î(·ÎÄø®Á¦ÀÌ¼Ç ¿ÍÀ̾î)
    • À¯¹æ »ý°Ë ¸¶Ä¿
  • Á¦Ç°º° ½ÃÀå ¸Å·Â ºÐ¼®

Á¦11Àå ÀûÀÀÁõº° : ¼¼°è ½ÃÀå ºÐ¼®

  • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(±Ý¾×) ¼®°ú ¿¹Ãø, 2024-2033³â
    • º¹ÇÕ ³¶Á¾
    • °íÇü µ¢¾î¸®
    • Àǽɽº·¯¿î °íÇü µ¢¾î¸®(¼¶À¯¼±Á¾)
    • Àǽɽº·¯¿î ¹Ì¼¼ ¼®È¸È­
  • ÀûÀÀÁõº° ½ÃÀå ¸Å·Â ºÐ¼®

Á¦12Àå ÃÖÁ¾»ç¿ëÀÚº° : ¼¼°è ½ÃÀå ºÐ¼®

  • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(±Ý¾×) ¼®°ú ¿¹Ãø, 2024-2033³â
    • º´¿ø
    • Àü¹® Ŭ¸®´Ð
    • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
    • ¾Ï Á¶»ç ±â°ü
  • ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå ¸Å·Â ºÐ¼®

Á¦13Àå Áö¿ªº° : ¼¼°è ½ÃÀå ºÐ¼®

  • ¼Ò°³
  • ½ÃÀå ±Ô¸ð(±Ý¾× ¹× ¼ö·®) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(±Ý¾× ¹× ¼ö·®) ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
    • ºÏ¹Ì
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • À¯·´
    • ³²¾Æ½Ã¾Æ
    • µ¿¾Æ½Ã¾Æ
    • ¿À¼¼¾Æ´Ï¾Æ
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
  • Áö¿ªº° ½ÃÀå ¸Å·Â ºÐ¼®

Á¦14Àå ºÏ¹Ì ½ÃÀå ºÐ¼®

Á¦15Àå ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®

Á¦16Àå À¯·´ ½ÃÀå ºÐ¼®

Á¦17Àå ³²¾Æ½Ã¾Æ ½ÃÀå ºÐ¼®

Á¦18Àå µ¿¾Æ½Ã¾Æ ½ÃÀå ºÐ¼®

Á¦19Àå ¿À¼¼¾Æ´Ï¾Æ ½ÃÀå ºÐ¼®

Á¦20Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå ºÐ¼®

Á¦21Àå ½ÃÀå ±¸Á¶ ºÐ¼®

  • ±â¾÷ °èÃþº° ½ÃÀå ºÐ¼®
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®(%)
  • ½ÃÀå ÀÔÁö ºÐ¼®

Á¦22Àå °æÀï ºÐ¼®

  • °æÀï ´ë½Ãº¸µå
  • ÁÖ¿ä ±â¾÷¿¡ ÀÇÇÑ ºê·£µù°ú ÇÁ·Î¸ð¼Ç Àü·«
  • ÁÖ¿ä °³¹ß ºÐ¼®
  • °æÀï »ó¼¼
    • Argon Medical Devices
    • Becton Dickinson and Company
    • CR Bard, Inc.
    • Cook Medical Inc.
    • Devicor Medical Products, Inc.
    • F. Hoffmann-La Roche Ltd.
    • GE Healthcare
    • Hologic, Inc.
    • Leica Biosystems
    • Medax Srl Unipersonale
    • Planmed Oy
    • Scion Medical Technologies, LLC
    • Siemens Healthineer

Á¦23Àå »ç¿ëµÇ´Â °¡Á¤°ú µÎ¹®ÀÚ¾î

Á¦24Àå Á¶»ç ¹æ¹ý

ksm 24.09.20

Persistence Market Research has recently published a detailed report on the global Breast Biopsy Market. This report offers an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, providing comprehensive insights into the market structure.

Key Insights:

  • Breast Biopsy Market Size (2024E): USD 2.3 Bn
  • Projected Market Value (2033F): USD 3.8 Bn
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.7%

Breast Biopsy Market - Report Scope:

The Breast Biopsy Market encompasses a variety of products designed to diagnose breast cancer by removing a small tissue sample for examination. This market includes different types of breast biopsy procedures, such as needle biopsy, open surgical biopsy, and vacuum-assisted biopsy, which are essential for early cancer detection and diagnosis. The market serves diverse segments, including hospitals, diagnostic centers, and ambulatory surgical centers, distributed through various channels like direct sales and medical supply distributors. Growth is driven by increasing awareness of breast cancer screening, rising prevalence of breast cancer, and technological advancements in biopsy techniques.

Market Growth Drivers:

Several key factors drive the global Breast Biopsy Market. The rising incidence of breast cancer globally boosts the demand for breast biopsy procedures. Technological advancements in biopsy devices and techniques enhance the accuracy and comfort of these procedures, fueling market expansion. Additionally, the growing awareness and initiatives for early breast cancer screening and diagnosis drive the demand for breast biopsy. Increased healthcare expenditure and a focus on preventive health measures also contribute to market growth.

Market Restraints:

Despite promising growth prospects, the Breast Biopsy Market faces challenges related to the high cost of advanced biopsy devices and procedures and potential issues associated with their use, such as discomfort and risk of infection. The market is also impacted by the presence of stringent regulations on medical device safety and the need for continuous innovation to meet evolving clinical needs. Effective patient education, competitive pricing, and ongoing investment in research and development are necessary to address these issues and maintain a competitive edge.

Market Opportunities:

The market presents significant opportunities driven by the rising trend of early cancer detection and increasing awareness about the benefits of breast cancer screening.The development of high-quality and minimally invasive biopsy devices caters to the growing demand for accurate and comfortable diagnostic solutions. The expansion of healthcare infrastructure in emerging economies provides new channels for market growth, allowing companies to reach a broader audience. Increasing urbanization and the rising number of health-conscious individuals drive the demand for breast biopsy procedures. Strategic partnerships, investments in new technologies, and the introduction of innovative biopsy devices are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Breast Biopsy Market globally?
  • Which types and applications of breast biopsy procedures are leading the adoption in various settings?
  • How are technological advancements influencing the competitive landscape of the Breast Biopsy Market?
  • Who are the key players in the Breast Biopsy Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Breast Biopsy Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Breast Biopsy Market, including Hologic, Inc., Becton, Dickinson and Company, and Leica Biosystems, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced biopsy devices and techniques, such as vacuum-assisted and stereotactic biopsy systems. Collaborations with healthcare providers, research institutions, and medical device distributors facilitate market access and promote new product adoption. Emphasis on patient education, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Breast Biopsy Market landscape.

Key Companies Profiled:

  • Argon Medical
  • Becton Dickinson and Company
  • C.R. Bard, Inc.
  • Cook Medical Inc.
  • Devicor Medical Products, Inc.
  • F. Hoffmann-La Roche Ltd.,
  • GE Healthcare
  • Hologic, Inc.
  • Leica Biosystems
  • Medax Srl Unipersonale
  • Planmed Oy
  • Scion Medical Technologies, LLC
  • Siemens Healthineers
  • Hikma Pharmaceuticals
  • Incytes

Breast Biopsy Market Industry Segmentation

By Product:

  • Biopsy Needles
  • MRI-Guide Biopsy Systems
  • Ultrasound Guided Breast Biopsy Systems
  • Vacuum-Assisted Devices (VAD)
  • Guide Wire (Localization Wire)
  • Breast Biopsy Markers

Indication:

  • Complex Cysts
  • Solid Mass
  • Suspicious Solid Mass (Fibroadenoma)
  • Suspicious Micro-calcifications

End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusion

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Value Added Insights

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Key Promotional Strategies, by Manufacturers
  • 4.3. Regulatory Scenario
  • 4.4. PESTLE Analysis
  • 4.5. Porter's Analysis
  • 4.6. New Product Launches
  • 4.7. Technology Assessment

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising demand for Breast Biopsy Devices
    • 5.2.2. Cost of Procedures
    • 5.2.3. Adoption Rate
    • 5.2.4. Increase in Research and Development
    • 5.2.5. Availability of Product
    • 5.2.6. Strategic Mergers and Collaborations Among Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue by Product
    • 6.1.2. Revenue By Indication
    • 6.1.3. Revenue By End User
    • 6.1.4. Revenue By Country
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Volume Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market- Pricing Analysis

  • 8.1. Regional Pricing Analysis by Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) & Volume (Units) Analysis by Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
    • 10.3.1. Biopsy Needle
      • 10.3.1.1. Core Needles
      • 10.3.1.2. Fine Aspiration Needles
    • 10.3.2. MRI-Guide Biopsy Systems
    • 10.3.3. Ultrasound Guided Breast Biopsy Systems
      • 10.3.3.1. Two-Dimensional (2-D) Mammographic Ultrasonic Scanning Systems
      • 10.3.3.2. Three-Dimensional (3-D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 10.3.4. Vacuum-Assisted Device (VAD)
    • 10.3.5. Guide Wire (Localization Wire)
    • 10.3.6. Breast Biopsy Marker
  • 10.4. Market Attractiveness Analysis by Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Indication

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis by Indication, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Indication, 2024-2033
    • 11.3.1. Complex Cyst
    • 11.3.2. Solid Mass
    • 11.3.3. Suspicious Solid Mass (Fibroadenoma)
    • 11.3.4. Suspicious Micro Calcifications
  • 11.4. Market Attractiveness Analysis by Indication

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Specialty Clinics
    • 12.3.3. Ambulatory Surgical Centers
    • 12.3.4. Cancer Research Institutes
  • 12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Region, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. South Asia
    • 13.3.5. East Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East & Africa(MEA)
  • 13.4. Market Attractiveness Analysis by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Indication
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. U.S. Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Indication
        • 14.8.1.2.3. By End User
    • 14.8.2. Canada Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Indication
        • 14.8.2.2.3. By End-User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast recast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Indication
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Brazil Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Indication
        • 15.8.1.2.3. By End User
    • 15.8.2. Mexico Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Indication
        • 15.8.2.2.3. By End User
    • 15.8.3. Argentina Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Indication
        • 15.8.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Nordic Countries
      • 16.3.1.8. Russia
      • 16.3.1.9. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Indication
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Germany Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Indication
        • 16.8.1.2.3. By End User
    • 16.8.2. Italy Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Indication
        • 16.8.2.2.3. By End User
    • 16.8.3. France Market
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Indication
        • 16.8.3.2.3. By End User
    • 16.8.4. U.K. Market
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Indication
        • 16.8.4.2.3. By End User
    • 16.8.5. Spain Market
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Indication
        • 16.8.5.2.3. By End User
    • 16.8.6. BENELUX Market
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Indication
        • 16.8.6.2.3. By End User
    • 16.8.7. Nordic Countries Market
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Indication
        • 16.8.7.2.3. By End User
    • 16.8.8. Russia Market
      • 16.8.8.1. Introduction
      • 16.8.8.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.8.2.1. By Product
        • 16.8.8.2.2. By Indication
        • 16.8.8.2.3. By End User

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Indication
    • 17.4.4. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. India Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Indication
        • 17.8.1.2.3. By End User
    • 17.8.2. Thailand Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Indication
        • 17.8.2.2.3. By End User
    • 17.8.3. Indonesia Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Indication
        • 17.8.3.2.3. By End User
    • 17.8.4. Malaysia Market
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Indication
        • 17.8.4.2.3. By End User

18. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Indication
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. China Market
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Indication
        • 18.8.1.2.3. By End User
    • 18.8.2. Japan Market
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Indication
        • 18.8.2.2.3. By End User
    • 18.8.3. South Korea Market
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Indication
        • 18.8.3.2.3. By End User

19. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Indication
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Indication
    • 19.4.4. By End User
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. Australia Market
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Indication
        • 19.8.1.2.3. By End User
    • 19.8.2. New Zealand Market
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Indication
        • 19.8.2.2.3. By End User

20. Middle East & Africa Market Analysis 2019-2023and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. South Africa
      • 20.3.1.4. North Africa
      • 20.3.1.5. Rest of MEA
    • 20.3.2. By Product
    • 20.3.3. By Indication
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Indication
    • 20.4.4. By End User
  • 20.5. Market Trends
  • 20.6. Key Market Participants - Intensity Mapping
  • 20.7. Drivers and Restraints - Impact Analysis
  • 20.8. Country Level Analysis & Forecast
    • 20.8.1. GCC Countries Market
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By Indication
        • 20.8.1.2.3. By End User
    • 20.8.2. Turkiye Market
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By Indication
        • 20.8.2.2.3. By End User
    • 20.8.3. South Africa Market
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.3.2.1. By Product
        • 20.8.3.2.2. By Indication
        • 20.8.3.2.3. By End User
    • 20.8.4. North Africa Market
      • 20.8.4.1. Introduction
      • 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.4.2.1. By Product
        • 20.8.4.2.2. By Indication
        • 20.8.4.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players (%)
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Branding and Promotional Strategies, by Key Players
  • 22.3. Key Development Analysis
  • 22.4. Competition Deep Dive
    • 22.4.1. Argon Medical Devices
      • 22.4.1.1. Overview
      • 22.4.1.2. Product Portfolio
      • 22.4.1.3. Key Financial
      • 22.4.1.4. Sales Footprint
      • 22.4.1.5. SWOT Analysis
      • 22.4.1.6. Strategy Overview
        • 22.4.1.6.1. Marketing Strategies
        • 22.4.1.6.2. Product Strategies
        • 22.4.1.6.3. Channel Strategies
    • 22.4.2. Becton Dickinson and Company
      • 22.4.2.1. Overview
      • 22.4.2.2. Product Portfolio
      • 22.4.2.3. Key Financial
      • 22.4.2.4. Sales Footprint
      • 22.4.2.5. SWOT Analysis
      • 22.4.2.6. Strategy Overview
        • 22.4.2.6.1. Marketing Strategies
        • 22.4.2.6.2. Product Strategies
        • 22.4.2.6.3. Channel Strategies
    • 22.4.3. C. R. Bard, Inc.
      • 22.4.3.1. Overview
      • 22.4.3.2. Product Portfolio
      • 22.4.3.3. Key Financial
      • 22.4.3.4. Sales Footprint
      • 22.4.3.5. SWOT Analysis
      • 22.4.3.6. Strategy Overview
        • 22.4.3.6.1. Marketing Strategies
        • 22.4.3.6.2. Product Strategies
        • 22.4.3.6.3. Channel Strategies
    • 22.4.4. Cook Medical Inc.
      • 22.4.4.1. Overview
      • 22.4.4.2. Product Portfolio
      • 22.4.4.3. Key Financial
      • 22.4.4.4. Sales Footprint
      • 22.4.4.5. SWOT Analysis
      • 22.4.4.6. Strategy Overview
        • 22.4.4.6.1. Marketing Strategies
        • 22.4.4.6.2. Product Strategies
        • 22.4.4.6.3. Channel Strategies
    • 22.4.5. Devicor Medical Products, Inc.
      • 22.4.5.1. Overview
      • 22.4.5.2. Product Portfolio
      • 22.4.5.3. Key Financial
      • 22.4.5.4. Sales Footprint
      • 22.4.5.5. SWOT Analysis
      • 22.4.5.6. Strategy Overview
        • 22.4.5.6.1. Marketing Strategies
        • 22.4.5.6.2. Product Strategies
        • 22.4.5.6.3. Channel Strategies
    • 22.4.6. F. Hoffmann-La Roche Ltd.
      • 22.4.6.1. Overview
      • 22.4.6.2. Product Portfolio
      • 22.4.6.3. Key Financial
      • 22.4.6.4. Sales Footprint
      • 22.4.6.5. SWOT Analysis
      • 22.4.6.6. Strategy Overview
        • 22.4.6.6.1. Marketing Strategies
        • 22.4.6.6.2. Product Strategies
        • 22.4.6.6.3. Channel Strategies
    • 22.4.7. GE Healthcare
      • 22.4.7.1. Overview
      • 22.4.7.2. Product Portfolio
      • 22.4.7.3. Key Financial
      • 22.4.7.4. Sales Footprint
      • 22.4.7.5. SWOT Analysis
      • 22.4.7.6. Strategy Overview
        • 22.4.7.6.1. Marketing Strategies
        • 22.4.7.6.2. Product Strategies
        • 22.4.7.6.3. Channel Strategies
    • 22.4.8. Hologic, Inc.
      • 22.4.8.1. Overview
      • 22.4.8.2. Product Portfolio
      • 22.4.8.3. Key Financial
      • 22.4.8.4. Sales Footprint
      • 22.4.8.5. SWOT Analysis
      • 22.4.8.6. Strategy Overview
        • 22.4.8.6.1. Marketing Strategies
        • 22.4.8.6.2. Product Strategies
        • 22.4.8.6.3. Channel Strategies
    • 22.4.9. Leica Biosystems
      • 22.4.9.1. Overview
      • 22.4.9.2. Product Portfolio
      • 22.4.9.3. Key Financial
      • 22.4.9.4. Sales Footprint
      • 22.4.9.5. SWOT Analysis
      • 22.4.9.6. Strategy Overview
        • 22.4.9.6.1. Marketing Strategies
        • 22.4.9.6.2. Product Strategies
        • 22.4.9.6.3. Channel Strategies
    • 22.4.10. Medax Srl Unipersonale
      • 22.4.10.1. Overview
      • 22.4.10.2. Product Portfolio
      • 22.4.10.3. Key Financial
      • 22.4.10.4. Sales Footprint
      • 22.4.10.5. SWOT Analysis
      • 22.4.10.6. Strategy Overview
        • 22.4.10.6.1. Marketing Strategies
        • 22.4.10.6.2. Product Strategies
        • 22.4.10.6.3. Channel Strategies
    • 22.4.11. Planmed Oy
      • 22.4.11.1. Overview
      • 22.4.11.2. Product Portfolio
      • 22.4.11.3. Key Financial
      • 22.4.11.4. Sales Footprint
      • 22.4.11.5. SWOT Analysis
      • 22.4.11.6. Strategy Overview
        • 22.4.11.6.1. Marketing Strategies
        • 22.4.11.6.2. Product Strategies
        • 22.4.11.6.3. Channel Strategies
    • 22.4.12. Scion Medical Technologies, LLC
      • 22.4.12.1. Overview
      • 22.4.12.2. Product Portfolio
      • 22.4.12.3. Key Financial
      • 22.4.12.4. Sales Footprint
      • 22.4.12.5. SWOT Analysis
      • 22.4.12.6. Strategy Overview
        • 22.4.12.6.1. Marketing Strategies
        • 22.4.12.6.2. Product Strategies
        • 22.4.12.6.3. Channel Strategies
    • 22.4.13. Siemens Healthineer
      • 22.4.13.1. Overview
      • 22.4.13.2. Product Portfolio
      • 22.4.13.3. Key Financial
      • 22.4.13.4. Sales Footprint
      • 22.4.13.5. SWOT Analysis
      • 22.4.13.6. Strategy Overview
        • 22.4.13.6.1. Marketing Strategies
        • 22.4.13.6.2. Product Strategies
        • 22.4.13.6.3. Channel Strategies

23. Assumptions and Acronyms Used

24. Research Methodology

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦